Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 26, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 28, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000310158-26-000024
Filed / recorded
Jan 28, 2026, 9:16 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Merck & Co., Inc.
Issuer CIK
310158
Ticker
MRK
Reporting person
Dalton E. Iii Smart
Relationship
Officer
Officer title
SVP Fin. - Global Controller
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jan 26, 2026
Transaction code
A
Shares / units
1,066
Price per share
$107.40
Acquired / disposed
Acquired (A)
Shares owned after
10,604.816
Ownership form
Direct
Amendment
No
Footnotes from the filing
Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/23. Performance shares were paid out at 94 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2025.
Holdings include shares acquired in dividend reinvestment transactions.